{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:29Z","timestamp":1792724969902,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52909-6","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:35:46Z","timestamp":1778528146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Design, synthesis, and multitarget evaluation of thiosemicarbazone\u2013sulfonamide hybrids as potent cholinesterase and MAO-A inhibitors with neuroblastoma-associated cytotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Khawar","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Rahmtalla","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyzi Sinan","family":"Tokali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa E.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima D.","family":"Alharthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"4","key":"52909_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2967\/jnmt.118.218057","volume":"46","author":"BJ Grabher","year":"2018","unstructured":"Grabher, B. J. Effects of Alzheimer disease on patients and their family. J. Nucl. Med. Technol. 46(4), 335\u2013340. https:\/\/doi.org\/10.2967\/jnmt.118.218057 (2018).","journal-title":"J. Nucl. Med. Technol."},{"key":"52909_CR2","doi-asserted-by":"publisher","first-page":"1524292","DOI":"10.3389\/fpsyg.2025.1524292","volume":"16","author":"L Mu\u00f1oz-Bermejo","year":"2025","unstructured":"Mu\u00f1oz-Bermejo, L. et al. Barrios-Fern\u00e1ndez, Effects of an interdisciplinary programme on psychoemotional factors in informal caregivers of people with Alzheimer\u2019s disease. Front. Psychol. 16, 1524292. https:\/\/doi.org\/10.3389\/fpsyg.2025.1524292 (2025).","journal-title":"Front. Psychol."},{"key":"52909_CR3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1186\/s12889-025-22378-z","volume":"25","author":"W Liu","year":"2025","unstructured":"Liu, W. et al. Global burden of Alzheimer\u2019s disease and other dementias in adults aged 65 years and over, and health inequality related to SDI, 1990\u20132021: analysis of data from GBD 2021. BMC Public. Health. 25, 1256. https:\/\/doi.org\/10.1186\/s12889-025-22378-z (2025).","journal-title":"BMC Public. Health"},{"key":"52909_CR4","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou, K. G. & Papageorgiou, S. G. Current and Future Treatments in Alzheimer Disease: An Update. J. Cent. Nerv. Sys Dis. 12, 1179573520907397. https:\/\/doi.org\/10.1177\/1179573520907397 (2020).","journal-title":"J. Cent. Nerv. Sys Dis."},{"key":"52909_CR5","doi-asserted-by":"publisher","first-page":"108863","DOI":"10.1016\/j.compbiolchem.2025.108683","volume":"120","author":"Y Demir","year":"2026","unstructured":"Demir, Y., \u015eenol, H., Ulu\u00e7ay, O., Ate\u015fo\u011flu, \u015e. & Tokal\u0131, F. S. Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer\u2019s key enzymes: From synthesis to inhibition. Comput. Biol. Chem. 120, 108863. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108683 (2026).","journal-title":"Comput. Biol. Chem."},{"key":"52909_CR6","doi-asserted-by":"publisher","first-page":"50186","DOI":"10.1039\/D5RA07416A","volume":"15","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131, F. S. et al. New Mannich-type arylidenerhodanines as potent inhibitors of AChE and BChE: synthesis, biological evaluation, cytotoxicity and molecular modeling. RSC Adv. 15, 50186\u201350205. https:\/\/doi.org\/10.1039\/D5RA07416A (2025).","journal-title":"RSC Adv."},{"issue":"14","key":"52909_CR7","doi-asserted-by":"publisher","first-page":"6980","DOI":"10.3390\/ijms26146980","volume":"26","author":"N Scarano","year":"2025","unstructured":"Scarano, N. et al. Alzheimer\u2019s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective. Int. J. Mol. Sci. 26(14), 6980. https:\/\/doi.org\/10.3390\/ijms26146980 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"52909_CR8","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1007\/s00217-025-04921-9","volume":"251","author":"R Sa\u011flamta\u015f","year":"2025","unstructured":"Sa\u011flamta\u015f, R., Demir, Y., K\u00fc\u00e7\u00fck, S., \u00d6zg\u00f6k\u00e7e, F. & \u00c7omakli, V. Exploring the multipharmacological potential of Rosa pisiformis: an integrated approach combining LC-MS\/MS, GC-MS, enzyme inhibition, docking, and pathway enrichment. Eur. Food Res. Technol. 251, 4719\u20134736. https:\/\/doi.org\/10.1007\/s00217-025-04921-9 (2025).","journal-title":"Eur. Food Res. Technol."},{"key":"52909_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11030-024-10828-6","volume":"29","author":"B Kuzu","year":"2025","unstructured":"Kuzu, B. et al. Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies. Mol. Divers. 29, 671\u2013693. https:\/\/doi.org\/10.1007\/s11030-024-10828-6 (2025).","journal-title":"Mol. Divers."},{"key":"52909_CR10","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s11696-025-03947-3","volume":"79","author":"B Kuzu","year":"2025","unstructured":"Kuzu, B. & Demir, Y. Imidazo[1,2\u2013a]pyridine mannich bases: synthesis, anticholinesterase evaluation, and in silico studies. Chem. Pap. 79, 2005\u20132018. https:\/\/doi.org\/10.1007\/s11696-025-03947-3 (2025).","journal-title":"Chem. Pap"},{"key":"52909_CR11","doi-asserted-by":"publisher","first-page":"105831","DOI":"10.1016\/j.neuint.2024.105831","volume":"179","author":"C Banerjee","year":"2024","unstructured":"Banerjee, C., Tripathy, D., Kumar, D. & Chakraborty, J. Monoamine oxidase and neurodegeneration: Mechanisms, inhibitors and natural compounds for therapeutic intervention. Neurochem Int. 179, 105831. https:\/\/doi.org\/10.1016\/j.neuint.2024.105831 (2024).","journal-title":"Neurochem Int."},{"issue":"12","key":"52909_CR12","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl, T. et al. Role of Monoamine Oxidase Activity in Alzheimer\u2019s Disease: An Insight into the Therapeutic Potential of Inhibitors. Molecules 26(12), 3724. https:\/\/doi.org\/10.3390\/molecules26123724 (2021).","journal-title":"Molecules"},{"key":"52909_CR13","doi-asserted-by":"publisher","first-page":"41752","DOI":"10.1038\/s41598-025-28665-4","volume":"15","author":"W Zareen","year":"2025","unstructured":"Zareen, W. et al. Design, synthesis, and computational insights into 3-acetyl-8-methoxy coumarin hybrids as potential anti-alzheimer\u2019s agents. Sci. Rep. 15, 41752. https:\/\/doi.org\/10.1038\/s41598-025-28665-4 (2025).","journal-title":"Sci. Rep."},{"issue":"5","key":"52909_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/ph18050629","volume":"18","author":"M Cokdinleyen","year":"2025","unstructured":"Cokdinleyen, M., Vald\u00e9s, A., Kara, H., Ib\u00e1\u00f1ez, E. & Cifuentes, A. Neuroprotective potential of Tetraselmis chuii compounds: insights into blood-brain barrier permeability and intestinal transport. Pharmaceuticals 18(5), 629. https:\/\/doi.org\/10.3390\/ph18050629 (2025).","journal-title":"Pharmaceuticals"},{"key":"52909_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2022.02.006","volume":"90","author":"S Onder","year":"2022","unstructured":"Onder, S., Schopfer, L. M., Jiang, W., Tacal, O. & Lockridge, O. Butyrylcholinesterase in SH-SY5Y human neuroblastoma cells. Neurotoxicology 90, 1\u20139. https:\/\/doi.org\/10.1016\/j.neuro.2022.02.006 (2022).","journal-title":"Neurotoxicology"},{"key":"52909_CR16","doi-asserted-by":"publisher","first-page":"108869","DOI":"10.1016\/j.bioorg.2025.108869","volume":"164","author":"G\u00c7 Turgut","year":"2025","unstructured":"Turgut, G. \u00c7., \u00c7ak\u0131r, F., \u015een, A., Tokal\u0131, F. S. & \u015eenol, H. Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations. Bioorg. Chem. 164, 108869. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108869 (2025).","journal-title":"Bioorg. Chem."},{"key":"52909_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","volume":"92","author":"L Lopez-Suarez","year":"2022","unstructured":"Lopez-Suarez, L., Awabdh, S. A., Coumoul, X. & Chauvet, C. The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: focus on organic pollutants. Neurotoxicology 92, 131\u2013155. https:\/\/doi.org\/10.1016\/j.neuro.2022.07.008 (2022).","journal-title":"Neurotoxicology"},{"issue":"12","key":"52909_CR18","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/etc.5490","volume":"41","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. Validation of an SH-SY5Y cell\u2013based acetylcholinesterase inhibition assay for water quality assessment. Environ. Toxicol. Chem. 41(12), 3046\u20133057. https:\/\/doi.org\/10.1002\/etc.5490 (2022).","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"52909_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ECB2023-14094","volume":"21","author":"M Donozo","year":"2023","unstructured":"Donozo, M., Cavallaro, V., Baier, C. J. & Murray, A. P. New resveratrol derivatives exhibit acetylcholinesterase inhibitory properties and decrease reactive oxygen species production in the SH-SY5Y human neuroblastoma cell line. Med. Sci. Forum. 21(1), 31. https:\/\/doi.org\/10.3390\/ECB2023-14094 (2023).","journal-title":"Med. Sci. Forum"},{"issue":"11","key":"52909_CR20","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/ph18111677","volume":"18","author":"E Mateev","year":"2025","unstructured":"Mateev, E. et al. Design, Synthesis, and Evaluation of Pyrrole-Based Selective MAO-B Inhibitors with Additional AChE Inhibitory and Neuroprotective Properties Identified via Virtual Screening. Pharmaceuticals 18(11), 1677. https:\/\/doi.org\/10.3390\/ph18111677 (2025).","journal-title":"Pharmaceuticals"},{"key":"52909_CR21","doi-asserted-by":"publisher","first-page":"114508","DOI":"10.1016\/j.inoche.2025.114508","volume":"178","author":"T Kele\u015f","year":"2025","unstructured":"Kele\u015f, T. et al. Highly water soluble metallophthalocyanines and investigation of their AChE\/BuChE enzyme inhibition and cytotoxic activity against human neuroblastoma (SH-SY5Y) cell. Inorg. Chem. Commun. 178, 114508. https:\/\/doi.org\/10.1016\/j.inoche.2025.114508 (2025).","journal-title":"Inorg. Chem. Commun."},{"key":"52909_CR22","doi-asserted-by":"publisher","first-page":"109364","DOI":"10.1016\/j.bioorg.2025.109364","volume":"168","author":"H Aftab","year":"2026","unstructured":"Aftab, H. et al. A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects. Bioorg. Chem. 168, 109364. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109364 (2026).","journal-title":"Bioorg. Chem."},{"issue":"19","key":"52909_CR23","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.3390\/molecules29194770","volume":"29","author":"X Mo","year":"2024","unstructured":"Mo, X. et al. Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery\u2014An Updated Review on Their Multifaceted Therapeutic Applications (2020\u20132024). Molecules 29(19), 4770. https:\/\/doi.org\/10.3390\/molecules29194770 (2024).","journal-title":"Molecules"},{"issue":"6","key":"52909_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4155\/fmc-2022-0228","volume":"15","author":"EM Azmy","year":"2023","unstructured":"Azmy, E. M. et al. New indole derivatives as multitarget anti-Alzheimer\u2019s agents: synthesis, biological evaluation and molecular dynamics. Future Med. Chem. 15(6), 473\u2013495. https:\/\/doi.org\/10.4155\/fmc-2022-0228 (2023).","journal-title":"Future Med. Chem."},{"key":"52909_CR25","doi-asserted-by":"publisher","first-page":"140511","DOI":"10.1016\/j.molstruc.2024","volume":"1322","author":"S. B Zahra","year":"2025","unstructured":"Zahra, S. B. et al.\u00a0Versatile biological activities of thiosemicarbazones and their metal complexes.\u00a0J. Mol. Struct. 1322, 40511\u00a0https:\/\/doi.org\/10.1016\/j.molstruc.2024.140511 (2025).","journal-title":"J. Mol. Struct."},{"key":"52909_CR26","doi-asserted-by":"publisher","unstructured":"Noreen, F. et al. Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as \u03b1-glucosidase and \u03b1-amylase inhibitors: integrating enzymatic evaluation and molecular modeling, RSC Adv. 16, 1662-1681 https:\/\/doi.org\/10.1039\/D5RA08761A (2026).","DOI":"10.1039\/D5RA08761A"},{"issue":"24","key":"52909_CR27","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1080\/17568919.2025.2592533","volume":"17","author":"FS Tokali","year":"2025","unstructured":"Tokali, F. S., \u015eenol, H., Ate\u015fo\u011flu, \u015e., Tokal\u0131, P. & Akba\u015f, F. Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone\/thiazolidin-4-one derivatives on PC3 cells. Future Med. Chem. 17(24), 2975\u20132986. https:\/\/doi.org\/10.1080\/17568919.2025.2592533 (2025).","journal-title":"Future Med. Chem."},{"key":"52909_CR28","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1039\/C4CE02566K","volume":"17","author":"R Jawaria","year":"2015","unstructured":"Jawaria, R. et al.\u00a0Robustness of thioamide dimer synthon, carbon bonding and thioamide\u2013thioamide stacking in ferrocene-based thiosemicarbazones. CrystEngComm. 17, 2553-2561\u00a0https:\/\/doi.org\/10.1039\/C4CE02566K (2015).","journal-title":"CrystEngComm"},{"issue":"4","key":"52909_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/jhet.4619","volume":"60","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S., \u015eenol, H., Gen\u00e7o\u011flu-Katmerlikaya, T., Da\u011f, A. & \u015eendil, K. Novel thiosemicarbazone and thiazolidin-4-one derivatives containing vanillin core: Synthesis, characterization, and anticancer activity studies. J. Het Chem. 60(4), 645\u2013656. https:\/\/doi.org\/10.1002\/jhet.4619 (2023).","journal-title":"J. Het Chem."},{"key":"52909_CR30","doi-asserted-by":"publisher","first-page":"129666","DOI":"10.1016\/j.molstruc.2020.129666","volume":"1231","author":"FS Tokal\u0131","year":"2021","unstructured":"Tokal\u0131, F. S., Taslimi, P., Usanmaz, H., Karaman, M. & \u015eendil, K. Synthesis, Characterization, Biological Activity and Molecular Docking Studies of Novel Schiff Bases Derived from Thiosemicarbazide: Biochemical and Computational Approach. J. Mol. Struct. 1231, 129666. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129666 (2021).","journal-title":"J. Mol. Struct."},{"issue":"6","key":"52909_CR31","doi-asserted-by":"publisher","first-page":"e202303927","DOI":"10.1002\/slct.202303927","volume":"9","author":"H \u015eenol","year":"2024","unstructured":"\u015eenol, H. 4-Furfuryloxymethyl-1,2,3-triazol-1-yl-acetohydrazide Hybrids as Cholinesterase and Carbonic Anhydrase Inhibitors: Synthesis, Characterization and Comprehensive Biological Activity Studies. ChemistrySelect 9(6), e202303927. https:\/\/doi.org\/10.1002\/slct.202303927 (2024).","journal-title":"ChemistrySelect"},{"issue":"39","key":"52909_CR32","doi-asserted-by":"publisher","first-page":"e202302448","DOI":"10.1002\/slct.202302448","volume":"8","author":"H \u015eenol","year":"2023","unstructured":"\u015eenol, H. & \u00c7ak\u0131r, F. 3-Amino-thiophene-2-carbohydrazide Derivatives as Anti Colon Cancer Agents: Synthesis, Characterization, In-Silico and In-Vitro Biological Activity Studies. ChemistrySelect 8(39), e202302448. https:\/\/doi.org\/10.1002\/slct.202302448 (2023).","journal-title":"ChemistrySelect"},{"issue":"5","key":"52909_CR33","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ddr.21667","volume":"81","author":"Y Demir","year":"2020","unstructured":"Demir, Y. Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases. Drug Develop Res. 81(5), 628\u2013636. https:\/\/doi.org\/10.1002\/ddr.21667 (2020).","journal-title":"Drug Develop Res."},{"issue":"4","key":"52909_CR34","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","volume":"17","author":"EB Miller","year":"2021","unstructured":"Miller, E. B. et al. Friesner, Reliable and Accurate Solution to the Induced Fit Docking Problem for Protein-Ligand Binding. J. Chem. Theory Comput. 17(4), 2630\u20132639. https:\/\/doi.org\/10.1021\/acs.jctc.1c00136 (2021).","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"52909_CR35","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1002\/ardp.70048","volume":"358","author":"H \u015eenol","year":"2025","unstructured":"\u015eenol, H. et al. 2-Propyl-3-Aminoquinazoline-4(3H)-one Derivatives as Potential Androgen Receptor Inhibitors: Synthesis and Cytotoxicity Against PC3 Cell Line via In Vitro and In Silico Studies. Arch. Pharm. 358(7), e70048. https:\/\/doi.org\/10.1002\/ardp.70048 (2025).","journal-title":"Arch. Pharm."},{"key":"52909_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cbi.2005.10.026","volume":"157","author":"A Ordentlich","year":"2005","unstructured":"Ordentlich, A. et al. The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers. Chem. Biol. Interact. 157, 191\u2013198. https:\/\/doi.org\/10.1016\/j.cbi.2005.10.026 (2005).","journal-title":"Chem. Biol. Interact."},{"key":"52909_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.etap.2017.12.014","volume":"57","author":"A Ranjan","year":"2018","unstructured":"Ranjan, A., Chauhan, A. & Jindal, T. In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates. Environ. Toxicol. Pharmacol. 57, 131\u2013140. https:\/\/doi.org\/10.1016\/j.etap.2017.12.014 (2018).","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"10","key":"52909_CR38","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3390\/ph17101407","volume":"17","author":"M Elsawalhy","year":"2024","unstructured":"Elsawalhy, M. et al. Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl\u2013Pyridazine Moiety for the Potential Treatment of Alzheimer\u2019s Disease. Pharmaceuticals 17(10), 1407. https:\/\/doi.org\/10.3390\/ph17101407 (2024).","journal-title":"Pharmaceuticals"},{"issue":"1","key":"52909_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1021\/acsmedchemlett.5c00524","volume":"17","author":"A Osama","year":"2026","unstructured":"Osama, A., Ji, M., Fang, J. & Zhang, B. Emergence of a Potent AChE Inhibitor with Antioxidant and Neuroprotection Abilities. ACS Med. Chem. Lett. 17(1), 137\u2013143. https:\/\/doi.org\/10.1021\/acsmedchemlett.5c00524 (2026).","journal-title":"ACS Med. Chem. Lett."},{"key":"52909_CR40","doi-asserted-by":"publisher","first-page":"30356","DOI":"10.1038\/s41598-024-81285-2","volume":"14","author":"K Rawat","year":"2024","unstructured":"Rawat, K. et al. Identification of AChE targeted therapeutic compounds for Alzheimer\u2019s disease: an in-silico study with DFT integration. Sci. Rep. 14, 30356. https:\/\/doi.org\/10.1038\/s41598-024-81285-2 (2024).","journal-title":"Sci. Rep."},{"issue":"20","key":"52909_CR41","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1021\/acschemneuro.5c00508","volume":"16","author":"S Jaman","year":"2025","unstructured":"Jaman, S., Tasmi, S. F., Shahriar, I. & Halim, M. A. Histidine Focused Covalent Inhibitors Targeting Acetylcholinesterase: A Computational Pipeline for Multisite Therapeutic Discovery in Alzheimer\u2019s Disease. ACS Chem. Neurosci. 16(20), 4025\u20134036. https:\/\/doi.org\/10.1021\/acschemneuro.5c00508 (2025).","journal-title":"ACS Chem. Neurosci."},{"key":"52909_CR42","doi-asserted-by":"publisher","first-page":"142192","DOI":"10.1016\/j.molstruc.2025.142192","volume":"1338","author":"P Patowary","year":"2025","unstructured":"Patowary, P. et al. Molecular modeling, synthesis, and In Vitro evaluation of AChE and BuChE inhibitory activity of novel N-thiazole substituted coumarin derivatives. J. Mol. Struct. 1338, 142192. https:\/\/doi.org\/10.1016\/j.molstruc.2025.142192 (2025).","journal-title":"J. Mol. Struct."},{"key":"52909_CR43","doi-asserted-by":"publisher","first-page":"100146","DOI":"10.1016\/j.crstbi.2024.100146","volume":"7","author":"M Sadeghi","year":"2024","unstructured":"Sadeghi, M., Seyedebrahibi, S., Ghanadian, M. & Miroliaei, M. Identification of cholinesterases inhibitors from flavonoids derivatives for possible treatment of Alzheimer\u2019s disease: In silico and in vitro approaches. Curr. Res. Struct. Biol. 7, 100146. https:\/\/doi.org\/10.1016\/j.crstbi.2024.100146 (2024).","journal-title":"Curr. Res. Struct. Biol."},{"issue":"10","key":"52909_CR44","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.3390\/molecules30102093","volume":"30","author":"L Li","year":"2025","unstructured":"Li, L. et al. Discovery, Biological Evaluation and Binding Mode Investigation of Novel Butyrylcholinesterase Inhibitors Through Hybrid Virtual Screening. Molecules 30(10), 2093. https:\/\/doi.org\/10.3390\/molecules30102093 (2025).","journal-title":"Molecules"},{"key":"52909_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.abb.2011.04.007","volume":"511","author":"K Biberoglu","year":"2011","unstructured":"Biberoglu, K., Tacal, \u00d6. & Akbulut, H. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase. Arch. Biochem. Biophys. 511, 64\u201368. https:\/\/doi.org\/10.1016\/j.abb.2011.04.007 (2011).","journal-title":"Arch. Biochem. Biophys."},{"issue":"21","key":"52909_CR46","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.3390\/molecules30214201","volume":"30","author":"MD Gambardella","year":"2025","unstructured":"Gambardella, M. D., Wang, Y. & Pang, J. The Selectivity of Butyrylcholinesterase Inhibitors Revisited. Molecules 30(21), 4201. https:\/\/doi.org\/10.3390\/molecules30214201 (2025).","journal-title":"Molecules"},{"key":"52909_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijbiomac.2022.01.136","volume":"203","author":"A Ganeshpurkar","year":"2022","unstructured":"Ganeshpurkar, A. et al. Identification of sulfonamide based butyrylcholinesterase inhibitors through scaffold hopping approach. Int. J. Biol. Macromol. 203, 195\u2013211. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.136 (2022).","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"52909_CR48","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/14756366.2019.1644329","volume":"34","author":"N Atatreh","year":"2019","unstructured":"Atatreh, N., Al Rawashdah, S., Al Neyadi, S. S., Abuhamdah, S. M. & Ghattas, M. A. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening. J. Enzyme Inhibit Med. Chem. 34(1), 1373\u20131379. https:\/\/doi.org\/10.1080\/14756366.2019.1644329 (2019).","journal-title":"J. Enzyme Inhibit Med. Chem."},{"key":"52909_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12031-013-0178-2","volume":"52","author":"SV Lushchekina","year":"2014","unstructured":"Lushchekina, S. V., Nemukhin, A. V., Varfolomeev, S. D. & Masson, P. Molecular Modeling Evidence for His438 Flip in the Mechanism of Butyrylcholinesterase Hysteretic Behavior. J. Mol. Neurosci. 52, 434\u2013445. https:\/\/doi.org\/10.1007\/s12031-013-0178-2 (2014).","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"52909_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbapap.2013.11.003","volume":"1844","author":"J Ju\u00e1rez-Jim\u00e9nez","year":"2014","unstructured":"Ju\u00e1rez-Jim\u00e9nez, J. et al. Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: Role of Asn181 and Ile335 validated by spectroscopic and computational studies. Biochim. Biophys. Acta. 1844(2), 389\u2013397. https:\/\/doi.org\/10.1016\/j.bbapap.2013.11.003 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"52909_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13659-015-0079-x","volume":"5","author":"AA Margret","year":"2015","unstructured":"Margret, A. A., Begum, T. N., Parthasarathy, S. & Suvaithenamudhan, S. A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression. Nat. Prod. Bioprospect. 5, 293\u2013306. https:\/\/doi.org\/10.1007\/s13659-015-0079-x (2015).","journal-title":"Nat. Prod. Bioprospect"},{"issue":"9","key":"52909_CR52","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3390\/molecules27092887","volume":"27","author":"S Bardaweel","year":"2022","unstructured":"Bardaweel, S., Aljanabi, R., Sabbah, D. & Sweidan, K. Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer. Molecules 27(9), 2887. https:\/\/doi.org\/10.3390\/molecules27092887 (2022).","journal-title":"Molecules"},{"issue":"22","key":"52909_CR53","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.3390\/molecules25225358","volume":"25","author":"ND Chaurasiya","year":"2020","unstructured":"Chaurasiya, N. D. et al. Selective Interactions of O-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B. Molecules 25(22), 5358. https:\/\/doi.org\/10.3390\/molecules25225358 (2020).","journal-title":"Molecules"},{"issue":"3","key":"52909_CR54","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/molecules24030418","volume":"24","author":"P Dhiman","year":"2019","unstructured":"Dhiman, P., Malik, N., Sobarzo-S\u00e1nchez, E., Uriarte, E. & Khatkar, A. Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders. Molecules 24(3), 418. https:\/\/doi.org\/10.3390\/molecules24030418 (2019).","journal-title":"Molecules"},{"issue":"11","key":"52909_CR55","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bmcl.2019.04.002","volume":"29","author":"N Sudhapriya","year":"2019","unstructured":"Sudhapriya, N., Manikandan, A., Kumar, M. R. & Perumal, P. T. Cu-mediated synthesis of differentially substituted diazepines as AChE inhibitors; validation through molecular docking and Lipinski\u2019s filter to develop novel anti-neurodegenerative drugs. Bioorg. Med. Chem. Lett. 29(11), 1308\u20131312. https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.002 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"52909_CR56","doi-asserted-by":"publisher","first-page":"117783","DOI":"10.1016\/j.poly.2025.117783","volume":"282","author":"PA Fatullayeva","year":"2025","unstructured":"Fatullayeva, P. A. et al. Vanadyl(III)-(E)-N\u2032-(3,5-di-tert-butyl-2-hydroxybenzylidene)-nicotinohydrazide complex: Synthesis, characterization and in vitro and in silico cholinesterase and \u03b1-glucosidase inhibition studies. Polyhedron 282, 117783. https:\/\/doi.org\/10.1016\/j.poly.2025.117783 (2025).","journal-title":"Polyhedron"},{"key":"52909_CR57","doi-asserted-by":"publisher","first-page":"144425","DOI":"10.1016\/j.molstruc.2025.144425","volume":"1352","author":"FS Tokal\u0131","year":"2026","unstructured":"Tokal\u0131, F. S. et al. Design and synthesis of new thienopyrimidine derivatives as potential anticancer agents: From cytotoxicity screening to VEGFR inhibition modeling. J. Mol. Struct. 1352, 144425. https:\/\/doi.org\/10.1016\/j.molstruc.2025.144425 (2026).","journal-title":"J. Mol. Struct."},{"issue":"17","key":"52909_CR58","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1055\/a-2541-1072","volume":"36","author":"\u015e Ate\u015fo\u011flu","year":"2025","unstructured":"Ate\u015fo\u011flu, \u015e. et al. Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents. Synlett 36(17), 2939\u20132947. https:\/\/doi.org\/10.1055\/a-2541-1072 (2025).","journal-title":"Synlett"},{"issue":"18","key":"52909_CR59","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/jcc.23637","volume":"35","author":"T Gaillard","year":"2014","unstructured":"Gaillard, T. & Simonson, T. Pairwise decomposition of an MMGBSA energy function for computational protein design. J. Comput. Chem. 35(18), 1371\u20131387. https:\/\/doi.org\/10.1002\/jcc.23637 (2014).","journal-title":"J. Comput. Chem."},{"issue":"3","key":"52909_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/17460441.2025.2467195","volume":"20","author":"G Apprato","year":"2025","unstructured":"Apprato, G. et al. Finding a needle in the haystack: ADME and pharmacokinetics\/pharmacodynamics characterization and optimization towards orally available bifunctional protein degraders. Expert Opin. Drug Discov. 20(3), 373\u2013389. https:\/\/doi.org\/10.1080\/17460441.2025.2467195 (2025).","journal-title":"Expert Opin. Drug Discov"},{"key":"52909_CR61","doi-asserted-by":"publisher","first-page":"140702","DOI":"10.1016\/j.molstruc.2024.140702","volume":"1322","author":"F \u00c7ak\u0131r","year":"2025","unstructured":"\u00c7ak\u0131r, F. et al. Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies. J. Mol. Struct. 1322, 140702. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140702 (2025).","journal-title":"J. Mol. Struct."},{"issue":"23","key":"52909_CR62","doi-asserted-by":"publisher","first-page":"13121","DOI":"10.3390\/ijms252313121","volume":"25","author":"K Wu","year":"2024","unstructured":"Wu, K. et al. Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches. Int. J. Mol. Sci. 25(23), 13121. https:\/\/doi.org\/10.3390\/ijms252313121 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"52909_CR63","doi-asserted-by":"publisher","first-page":"35790","DOI":"10.1039\/D5RA04242A","volume":"15","author":"RR Suradkar","year":"2025","unstructured":"Suradkar, R. R., Gholap, D. P., Belambe, A. V. & Lande, M. K. Synthesis and computational evaluation of imidazole-based functional materials for applications in sensing and detection: modulating electronic effects for enhanced performance. RSC Adv. 15, 35790\u201335806. https:\/\/doi.org\/10.1039\/D5RA04242A (2025).","journal-title":"RSC Adv."},{"key":"52909_CR64","doi-asserted-by":"publisher","first-page":"138330","DOI":"10.1016\/j.molstruc.2024.138330","volume":"1308","author":"MD Mellaoui","year":"2024","unstructured":"Mellaoui, M. D. et al. In silico anticancer activity of isoxazolidine and isoxazolines derivatives: DFT study, ADMET prediction, and molecular docking. J. Mol. Struct. 1308, 138330. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138330 (2024).","journal-title":"J. Mol. Struct."},{"key":"52909_CR65","doi-asserted-by":"publisher","first-page":"22801","DOI":"10.1038\/s41598-024-72846-6","volume":"14","author":"NM Sabry","year":"2024","unstructured":"Sabry, N. M., Badry, R., Abdel-Gawad, F. K., Elhaes, H. & Ibrahim, M. A. Electronic structure, global reactivity descriptors and nonlinear optical properties of glycine interacted with ZnO, MgO and CaO for bacterial detection. Sci. Rep. 14, 22801. https:\/\/doi.org\/10.1038\/s41598-024-72846-6 (2024).","journal-title":"Sci. Rep."},{"key":"52909_CR66","doi-asserted-by":"publisher","first-page":"109252","DOI":"10.1016\/j.bioorg.2025.109252","volume":"167","author":"Z Batool","year":"2025","unstructured":"Batool, Z. et al. Dual targeting of neuroblastoma and cholinesterase by morpholino\/pyrrolidino-sulfonyl-indole thiosemicarbazones: Synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies. Bioorg. Chem. 167, 109252. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109252 (2025).","journal-title":"Bioorg. Chem."},{"issue":"4","key":"52909_CR67","doi-asserted-by":"publisher","first-page":"2200554","DOI":"10.1002\/ardp.202200554","volume":"356","author":"Y Demir","year":"2023","unstructured":"Demir, Y. et al. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Arch. Pharm. 356(4), 2200554. https:\/\/doi.org\/10.1002\/ardp.202200554 (2023).","journal-title":"Arch. Pharm."},{"key":"52909_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman, G. L., Courtney, K. D., Andres, V. Jr & Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9 (1961).","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"52909_CR69","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/ja01318a036","volume":"56","author":"H Lineweaver","year":"1934","unstructured":"Lineweaver, H. & Burk, D. The Determination of Enzyme Dissociation Constants. J. Am. Chem. Soc. 56(3), 658\u2013666. https:\/\/doi.org\/10.1021\/ja01318a036 (1934).","journal-title":"J. Am. Chem. Soc."},{"key":"52909_CR70","doi-asserted-by":"publisher","first-page":"108614","DOI":"10.1016\/j.bioorg.2025.108614","volume":"162","author":"P Tokal\u0131","year":"2025","unstructured":"Tokal\u0131, P., Demir, Y., \u00c7ak\u0131r, F., \u015eenol, H. & Tokal\u0131, F. S. Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality. Bioorg. Chem. 162, 108614. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108614 (2025).","journal-title":"Bioorg. Chem."},{"issue":"7","key":"52909_CR71","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/ardp.70034","volume":"358","author":"U Ghaffar","year":"2025","unstructured":"Ghaffar, U. et al. Synthesis, Anti-Alzheimer Evaluation and In Silico Study of 4-Methoxyphenyl)Sulfonyl Indole Hybrid Thiosemicarbazones. Arch. Pharm. 358(7), e70034. https:\/\/doi.org\/10.1002\/ardp.70034 (2025).","journal-title":"Arch. Pharm."},{"key":"52909_CR72","doi-asserted-by":"publisher","first-page":"117915","DOI":"10.1016\/j.ejmech.2025.117915","volume":"296","author":"EN Ay","year":"2025","unstructured":"Ay, E. N. et al. Synthesis, characterization, In vitro and In silico investigations of novel 1,2,3-triazole substituted salicylic acid phenolic hydrazones hybrids targeting TGF-\u03b22 expression in colorectal carcinoma. Eur. J. Med. Chem. 296, 117915. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117915 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"52909_CR73","doi-asserted-by":"publisher","first-page":"127487","DOI":"10.1016\/j.molliq.2025.127487","volume":"426","author":"FS Tokal\u0131","year":"2025","unstructured":"Tokal\u0131, F. S. et al. Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications. J. Mol. Liq. 426, 127487. https:\/\/doi.org\/10.1016\/j.molliq.2025.127487 (2025).","journal-title":"J. Mol. Liq"},{"key":"52909_CR74","doi-asserted-by":"publisher","first-page":"125006","DOI":"10.1016\/j.molliq.2024.125006","volume":"404","author":"I Mamedov","year":"2024","unstructured":"Mamedov, I. et al. New tetrahydro-isoquinoline derivatives as cholinesterase and \u03b1-glycosidase inhibitors: Synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studies. J. Mol. Liq. 404, 125006. https:\/\/doi.org\/10.1016\/j.molliq.2024.125006 (2024).","journal-title":"J. Mol. Liq"},{"key":"52909_CR75","doi-asserted-by":"publisher","first-page":"105822","DOI":"10.1016\/j.bioorg.2022.105822","volume":"124","author":"C Yamali","year":"2022","unstructured":"Yamali, C. et al. Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies. Bioorg. Chem. 124, 105822. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105822 (2022).","journal-title":"Bioorg. Chem."},{"key":"52909_CR76","doi-asserted-by":"publisher","first-page":"106288","DOI":"10.1016\/j.compbiomed.2022.106288","volume":"151","author":"Z Yang","year":"2022","unstructured":"Yang, Z. et al. Exploring new catechin derivatives as SARS-CoV-2 Mpro inhibitors from tea by molecular networking, surface plasma resonance, enzyme inhibition, induced fit docking, and metadynamics simulations. Comput. Biol. Med. 151, 106288. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106288 (2022).","journal-title":"Comput. Biol. Med."},{"key":"52909_CR77","doi-asserted-by":"publisher","first-page":"138998","DOI":"10.1016\/j.molstruc.2024.138998","volume":"1315","author":"OV Petrova","year":"2024","unstructured":"Petrova, O. V. et al. Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: An in vitro-in silico study. J. Mol. Struct. 1315, 138998. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138998 (2024).","journal-title":"J. Mol. Struct."},{"key":"52909_CR78","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.compbiolchem.2025.108486","volume":"118","author":"H \u015eenol","year":"2025","unstructured":"\u015eenol, H., K\u0131l\u0131n\u00e7, N., \u00c7ak\u0131r, F., Albay, G. & Tokal\u0131, F. S. Synthesis and evaluation of aldose reductase inhibition of new thiazolidine-quinazoline hybrids through in vitro and in silico approaches. Comput. Biol. Chem. 118, 108486. https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108486 (2025).","journal-title":"Comput. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52909-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:13:27Z","timestamp":1779268407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52909"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52909-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15736"}}